Literature DB >> 17353260

Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention.

Zhao V Wang1, Todd D Schraw, Ja-Young Kim, Tayeba Khan, Michael W Rajala, Antonia Follenzi, Philipp E Scherer.   

Abstract

Adiponectin is a secretory protein abundantly secreted from adipocytes. It assembles into a number of different higher-order complexes. Adipocytes maintain tight control over circulating plasma levels, suggesting the existence of a complex, highly regulated biosynthetic pathway. However, the critical mediators of adiponectin maturation within the secretory pathway have not been elucidated. Previously, we found that a significant portion of de novo-synthesized adiponectin is not secreted and retained in adipocytes. Here, we show that there is an abundant pool of properly folded adiponectin in the secretory pathway that is retained through thiol-mediated retention, as judged by the release of adiponectin in response to treatment of adipocytes with reducing agents. Adiponectin is covalently bound to the ER chaperone ERp44. An adiponectin mutant lacking cysteine 39 fails to stably interact with ERp44, demonstrating that this residue is the primary site mediating the covalent interaction. Another ER chaperone, Ero1-Lalpha, plays a critical role in the release of adiponectin from ERp44. Levels of both of these proteins are highly regulated in adipocytes and are influenced by the metabolic state of the cell. While less critical for the secretion of trimers, these chaperones play a major role in the assembly of higher-order adiponectin complexes. Our data highlight the importance of posttranslational events controlling adiponectin levels and the release of adiponectin from adipocytes. One mechanism for increasing circulating levels of specific adiponectin complexes by peroxisome proliferator-activated receptor gamma agonists may be selective upregulation of rate-limiting chaperones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353260      PMCID: PMC1899995          DOI: 10.1128/MCB.00931-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

2.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.

Authors:  Terry P Combs; Utpal B Pajvani; Anders H Berg; Ying Lin; Linda A Jelicks; Mathieu Laplante; Andrea R Nawrocki; Michael W Rajala; Albert F Parlow; Laurelle Cheeseboro; Yang-Yang Ding; Robert G Russell; Dirk Lindemann; Adam Hartley; Glynn R C Baker; Silvana Obici; Yves Deshaies; Marian Ludgate; Luciano Rossetti; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

3.  Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.

Authors:  Utpal B Pajvani; Xueliang Du; Terry P Combs; Anders H Berg; Michael W Rajala; Therese Schulthess; Jürgen Engel; Michael Brownlee; Philipp E Scherer
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

4.  Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.

Authors:  Andrew N Carley; Lisa M Semeniuk; Yakhin Shimoni; Ellen Aasum; Terje S Larsen; Joel P Berger; David L Severson
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-11-04       Impact factor: 4.310

5.  Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Authors:  Utpal B Pajvani; Meredith Hawkins; Terry P Combs; Michael W Rajala; Tom Doebber; Joel P Berger; John A Wagner; Margaret Wu; Annemie Knopps; Anny H Xiang; Kristina M Utzschneider; Steven E Kahn; Jerrold M Olefsky; Thomas A Buchanan; Philipp E Scherer
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

6.  Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Authors:  Julia Tonelli; Weijie Li; Preeti Kishore; Utpal B Pajvani; Elize Kwon; Charles Weaver; Philipp E Scherer; Meredith Hawkins
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

7.  Thiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44.

Authors:  Tiziana Anelli; Massimo Alessio; Angela Bachi; Leda Bergamelli; Gloria Bertoli; Serena Camerini; Alexandre Mezghrani; Elena Ruffato; Thomas Simmen; Roberto Sitia
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

9.  Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion.

Authors:  Eelco van Anken; Edwin P Romijn; Claudia Maggioni; Alexandre Mezghrani; Roberto Sitia; Ineke Braakman; Albert J R Heck
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

10.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.

Authors:  Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Atsushi Tsuchida; Takehiko Yokomizo; Shunbun Kita; Takuya Sugiyama; Makoto Miyagishi; Kazuo Hara; Masaki Tsunoda; Koji Murakami; Toshiaki Ohteki; Shoko Uchida; Sato Takekawa; Hironori Waki; Nelson H Tsuno; Yoichi Shibata; Yasuo Terauchi; Philippe Froguel; Kazuyuki Tobe; Shigeo Koyasu; Kazunari Taira; Toshio Kitamura; Takao Shimizu; Ryozo Nagai; Takashi Kadowaki
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962

View more
  108 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

2.  Mitochondrial dysfunction in white adipose tissue.

Authors:  Christine M Kusminski; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2012-07-10       Impact factor: 12.015

3.  Maternal overweight programs insulin and adiponectin signaling in the offspring.

Authors:  Kartik Shankar; Ping Kang; Amanda Harrell; Ying Zhong; John C Marecki; Martin J J Ronis; Thomas M Badger
Journal:  Endocrinology       Date:  2010-04-06       Impact factor: 4.736

4.  Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.

Authors:  Zhongjie Fu; Chatarina A Lofqvist; Zhuo Shao; Ye Sun; Jean-Sebastien Joyal; Christian G Hurst; Ricky Z Cui; Lucy P Evans; Katherine Tian; John Paul SanGiovanni; Jing Chen; David Ley; Ingrid Hansen Pupp; Ann Hellstrom; Lois E H Smith
Journal:  Am J Clin Nutr       Date:  2015-02-04       Impact factor: 7.045

Review 5.  Protein quality control in the early secretory pathway.

Authors:  Tiziana Anelli; Roberto Sitia
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

6.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

8.  Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.

Authors:  Changtao Jiang; Jung-Hwan Kim; Fei Li; Aijuan Qu; Oksana Gavrilova; Yatrik M Shah; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  Plasma adiponectin complexes have distinct biochemical characteristics.

Authors:  Todd Schraw; Zhao V Wang; Nils Halberg; Meredith Hawkins; Philipp E Scherer
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

10.  Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.

Authors:  Shira Landskroner-Eiger; Binzhi Qian; Eric S Muise; Andrea R Nawrocki; Joel P Berger; Eugene J Fine; Wade Koba; Yingfeng Deng; Jeffrey W Pollard; Philipp E Scherer
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.